In a 1976 study, Ishikawa and Hamada observed high CEA values in patients diagnosed postoperatively with MTC, and they even made an initial correlation of the slow decline in CEA in patients with advanced disease [11]. This evidence concerns the gene CEACAM3 and medullary thyroid gland carcinoma.